Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival-Reference-Cited by-同舟云学术

Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival

Published:2021-10-03 Issue:2 Volume:29 Page:1172-1179
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kim Jin K.,Thompson Hannah,Jimenez-Rodriguez Rosa M.,Wu Fan,Sanchez-Vega Francisco,Nash Garrett M.,Guillem Jose G.,Paty Philip B.,Wei Iris H.,Pappou Emmanouil P.,Widmar Maria,Weiser Martin R.,Smith J. Joshua,Garcia-Aguilar Julio

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-10877-3.pdf

Reference44 articles.

1. Appelt AL, Ploen J, Harling H, et al. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol. 2015;16(8):919–27.

2. Habr-Gama A, Sao Juliao GP, Vailati BB, et al. Organ preservation in cT2N0 rectal cancer after neoadjuvant chemoradiation therapy: the impact of radiation therapy dose-escalation and consolidation chemotherapy. Ann Surg. 2019;269(1):102–7.

3. Garcia-Aguilar J, Chow OS, Smith DD, et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015;16(8):957–66.

4. Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29–42.

5. George TJ, Yothers G, Hong TS, et al. NRG-GI002: a phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—first experimental arm (EA) initial results. J Clin Oncol. 2019;37(15 Suppl):3505.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor response rates based on initial TNM stage and tumor size in locally advanced rectal cancer: a useful tool for shared decision-making;Techniques in Coloproctology;2024-09-10

2. SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021);Clinical and Translational Oncology;2022-03-18

3. ASO Author Reflections: Identifying Rectal Cancer Patients Suitable for Watch-and-Wait;Annals of Surgical Oncology;2021-10-06